Skip to main content
profile image
Selected Works of Ripal Gandhi
Article
Resection Rate of Locally Advanced Pancreatic Cancer in Gemcitabine Plus Nab-paclitaxel versus FOLFIRINOX
Journal of Clinical Oncology (2021)
  • Ripal Gandhi, Baptist Health South Florida
  • Shahriar Sharif
  • Amer H. Zureikat, University of Pittsburgh
  • Paula M. Novelli, University of Pittsburgh
  • Charles D. Lopez, Oregon Health & Science University
  • Adel Kardosh, Oregon Health & Science University
  • Ki Y. Chung, Institute for Translational Oncology Research, Prisma Health-Upstate Cancer Institute, Greenville, SC;
  • Wesley B. Jones, Greenville Health System
  • Hassan Hatoum, University of Oklahoma Health Sciences Center
  • Kenneth Lee Meredith, Florida State University
  • Emmanuel E. Zervos, University of South Florida
  • Antonio Ucar, University of Miami
Link
Disciplines
Publication Date
2021
Citation Information
Ripal Gandhi, Shahriar Sharif, Amer H. Zureikat, Paula M. Novelli, et al.. "Resection Rate of Locally Advanced Pancreatic Cancer in Gemcitabine Plus Nab-paclitaxel versus FOLFIRINOX" Journal of Clinical Oncology Vol. 39 Iss. 3 Supplement (2021) p. 381 - 381
Available at: http://works.bepress.com/ripal-gandhi/453/